Global Cardiovascular Drugs Market Overview, Trends and Drivers
- Get link
- X
- Other Apps
Hypertension, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease are some of the most common cardiovascular illnesses. Angina, hypertrophy, and heart failure are all major complications of hypertensive heart disease. High blood pressure in the heart's arteries and muscles promotes narrowing of the arteries, as well as thickening and enlargement of the heart.
The global cardiovascular drugs market is
primarily driven by increased heart disease prevalence, as well as an ageing
population and lifestyle-related disorders. Drugs for the treatment and
prevention of cardiovascular disorders are needed to cater to the growing population
suffering from these diseases. Another factor projected to drive the global
cardiovascular drugs market is an increase in the number of diabetes
patients. According to the American Diabetes Association, 30.3 million
Americans (9.4% of the total population) had diabetes in 2015.
Cardiovascular Drugs Market |
Trends:
Cardiovascular
disease is one of the most common causes of death in the world. According to
the American Heart Association, roughly 41.5 percent of the population in the
United States had some type of cardiovascular disease in 2015, and this
prevalence is expected to rise to 45 percent by 2035. The number of patients
with cardiovascular illnesses is projected to rise as a result of sedentary
lifestyles, changing food choices, and an increase in associated risk factors.
High blood
pressure, high cholesterol, and smoking, according to the US Centers for
Disease Control and Prevention (CDC), are all major risk factors for heart
disease. At least one of these three risk factors affects over half of the
population in the United States (47 percent). To combat the diseases, major
firms are investing in the development of new treatments that are more
effective and have fewer adverse effects.
Drivers:
Increase in number of cardiovascular
disease:
The number
of deaths from cardiovascular diseases is increasing as the world's population
approaches 7 billion people and more people reach old age. Heart attacks,
strokes, and other circulatory illnesses are among the main causes of premature
death around the world. As a result, efforts to prevent and cure cardiovascular
illnesses through medicine are increasing, resulting in a decreased death rate
and more business for the cardiovascular drug industry.
In addition,
there is a rise in cigarette use, poor diet and obesity, physical inactivity,
and problematic alcohol consumption, all of which contribute to an increase in
CVD and the need for medication.
- Get link
- X
- Other Apps
Comments
Post a Comment